Genus PLC (LON:GNS) Stock Buy Rating Reconfirmed at Liberum Capital; The TP is GBX 1950.00; Allianzgi Convertible & Income Fund II (NCZ) Sentiment Is 2.23

August 24, 2017 - By Marguerite Chambers

Liberum Capital have a GBX 1950.00 target price per share on the stock. The target price per share indicates a potential upside of 5.86% from Genus PLC (LON:GNS)‘s last close price. This rating was released in a note on Thursday morning.

AllianzGI Convertible & Income Fund II , formerly AGIC Convertible & Income Fund II, is a diversified, closed-end management investment company. The company has market cap of $462.94 million. The Fund’s investment objective is to provide total return through a combination of capital appreciation and high current income. It has a 3.21 P/E ratio. The Fund focuses on investing approximately 50% of its portfolio in convertibles, but determines its allocation based on changes in equity prices, changes in interest rates and other economic and market factors.

The stock increased 0.16% or $0.01 on August 23, reaching $6.21. About shares traded. Allianzgi Convertible & Income Fund II (NCZ) has risen 18.50% since August 24, 2016 and is uptrending. It has outperformed by 1.80% the S&P500.

Robinson Capital Management Llc holds 1.44% of its portfolio in Allianzgi Convertible & Income Fund II for 464,826 shares. Sit Investment Associates Inc owns 1.13 million shares or 0.17% of their US portfolio. Moreover, Advisors Asset Management Inc. has 0.09% invested in the company for 967,529 shares. The New York-based National Asset Management Inc. has invested 0.06% in the stock. Advisory Alpha Llc, a Michigan-based fund reported 12,263 shares.

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The company has market cap of 1.13 billion GBP. The Company’s divisions include Genus PIC, Genus ABS, Genus Asia, and Research and Development. It has a 24.13 P/E ratio. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine clients in North America, Latin America and Europe.

Among 7 analysts covering Genus PLC (LON:GNS), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Genus PLC has GBX 2600 highest and GBX 1424 lowest target. GBX 1892’s average target is 2.77% above currents GBX 1841 stock price. Genus PLC had 79 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Genus plc (LON:GNS) has “Hold” rating given on Monday, April 3 by N+1 Singer. The firm earned “Buy” rating on Thursday, June 1 by Liberum Capital. On Tuesday, September 1 the stock rating was maintained by Liberum Capital with “Buy”. Liberum Capital downgraded Genus plc (LON:GNS) rating on Friday, September 9. Liberum Capital has “Hold” rating and GBX 1950 target. The firm has “Buy” rating given on Monday, October 12 by Liberum Capital. The company was initiated on Friday, September 11 by HSBC. Peel Hunt maintained the stock with “Buy” rating in Tuesday, February 23 report. Liberum Capital maintained the shares of GNS in report on Monday, November 9 with “Buy” rating. On Thursday, November 19 the stock rating was maintained by Liberum Capital with “Hold”. The firm has “Buy” rating by Liberum Capital given on Thursday, March 2.

About 11,034 shares traded. Genus plc (LON:GNS) has 0.00% since August 24, 2016 and is . It has underperformed by 16.70% the S&P500.